← All trials
NCT05463484
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2021
- Primary completion
- Feb 28, 2023
- Completion date
- Jul 15, 2023
- First posted
- Jul 19, 2022
- Last posted
- Jul 8, 2024
- Enrollment
- 100
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mucosa Innovations, S.L.Lead sponsor
- University of GranadaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.